| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/04/2014 | US8642753 Modulation of glucagon receptor expression |
| 02/04/2014 | US8642752 Modulation of Hepatitis B virus (HBV) expression |
| 02/04/2014 | US8642749 Regulatory region preferentially expressing to seed embryo and method of using same |
| 02/04/2014 | US8642748 Elite event EE-GM3 and methods and kits for identifying such event in biological samples |
| 02/04/2014 | US8642747 Genetic modification of targeted regions of the cardiac conduction system |
| 02/04/2014 | US8642745 Method for making multispecific antibodies having heteromultimeric and common components |
| 02/04/2014 | US8642741 Human antibodies to human TNF-like ligand 1A (TL1A) |
| 02/04/2014 | US8642738 Modified vitamin K-dependent polypeptides |
| 02/04/2014 | US8642732 Polymer-conjugated glycosylated neublastin |
| 02/04/2014 | US8642730 Endoglucanases |
| 02/04/2014 | US8642571 Therapeutic uses of inhibitors of RTP801 |
| 02/04/2014 | US8642570 ASLV vector system |
| 02/04/2014 | US8642569 Methods for expansion of hematopoietic stem and progenitor cells |
| 02/04/2014 | US8642564 Compositions for drug administration |
| 02/04/2014 | US8642560 Template fixed β-hairpin loop mimetics and their use in phage display |
| 02/04/2014 | US8642542 Recombinant fusion proteins to growth hormone and serum albumin |
| 02/04/2014 | US8642537 Hepatitis B virus-binding polypeptides and methods of use thereof |
| 02/04/2014 | US8642357 Semaphorin 7A plays a critical role in TGF-β1-induced pulmonary fibrosis and alveolar destruction |
| 02/04/2014 | US8642342 Methods for regulating neural differentiation |
| 02/04/2014 | US8642341 Materials and methods for gene mediated therapy of psychiatric disorders |
| 02/04/2014 | US8642330 Antibody compositions, methods for treating neoplastic disease and methods for regulating fertility |
| 02/04/2014 | US8642328 Derivation of embryonic stem cells |
| 02/04/2014 | US8642327 Vector for inhibition-based high-throughput screen strategy |
| 02/04/2014 | US8642298 Production of itaconic acid |
| 02/04/2014 | US8642292 Process for producing molecules containing specialized glycan structures |
| 02/04/2014 | US8642272 Isolated luciferase gene of L. italica |
| 02/04/2014 | US8642269 Detection of nucleic acid sequence differences using coupled polymerase chain reactions |
| 02/04/2014 | US8642259 Method for identifying substances capable of modulating the activity of a target molecule |
| 02/04/2014 | US8642257 Vaccinia virus for diagnosis and therapy of tumors |
| 02/04/2014 | US8642050 Gonococcal proteins and nucleic acids |
| 02/04/2014 | US8642045 Recombinant virus vector originating in HHV-6 or HHV-7, method of producing the same, method of transforming host cell using the same, host cell transformed thereby and gene therapy method using the same |
| 02/04/2014 | US8642044 Prevention and treatment of amyloidogenic disease |
| 02/04/2014 | US8642037 Antibodies to insulin-like growth factor I receptor |
| 02/04/2014 | US8642036 Treatment with anti-ErbB2 antibodies |
| 02/04/2014 | US8642028 Recombinant adenoviruses encoding the specific iodine transporter (NIS) |
| 02/04/2014 | CA2807515C Alphavirus particles and methods for preparation |
| 02/04/2014 | CA2697520C Use of lyophilised reduced diaminophenothiazines in the treatment of tau mediated neurological disorders |
| 02/04/2014 | CA2619533C Sirna-hydrophilic polymer conjugates for intracellular delivery of sirna and method thereof |
| 02/04/2014 | CA2607645C Method for transformation using mutant acetolactate synthase gene |
| 02/04/2014 | CA2600989C Phosphorylated waxy potato starch |
| 02/04/2014 | CA2581099C Enzymes involved in triterpene synthesis |
| 02/04/2014 | CA2553485C Multicopy-integration of heterologous genes and expression in methylobacterium |
| 02/04/2014 | CA2547655C Novel centromeric protein shugoshin |
| 02/04/2014 | CA2535836C High efficiency gene transfer and expression in mammalian cells by a multiple transfection procedure of mar sequences |
| 02/04/2014 | CA2516727C Hypoxia inducible vegf plasmid for ischemic disease |
| 02/04/2014 | CA2501957C Assay for imidazolinone resistance mutations in brassica species |
| 02/04/2014 | CA2442533C A simplified and improved method for preparing an antibody or an antibody fragment targeted immunoliposome or polyplex for systemic administration of a therapeutic or diagnostic agent |
| 02/04/2014 | CA2410263C Purification of a triple helix formation with an immobilized oligonucleotide |
| 02/04/2014 | CA2326388C A polypeptide comprising the amino acid of an n-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof |
| 02/04/2014 | CA2301879C Tuberculosis vaccine |
| 02/04/2014 | CA2274801C Mammalian cell surface antigens; related reagents |
| 01/30/2014 | WO2014018982A1 Systems and methods for enhancing gene expression |
| 01/30/2014 | WO2014018930A1 Modulation of renin-angiotensin system (ras) related diseases by angiotensinogen |
| 01/30/2014 | WO2014018904A1 Fused antigen vaccines and compositions against streptococcus pneumoniae |
| 01/30/2014 | WO2014018863A1 Engineering t-cell receptors |
| 01/30/2014 | WO2014018853A1 Novel insecticidal proteins and methods for their use |
| 01/30/2014 | WO2014018849A1 Preparation of biological devices and their use thereof for increasing the production of secondary metabolites from plants |
| 01/30/2014 | WO2014018822A2 Methods for increasing the production of phenolic compounds from theobroma cacao |
| 01/30/2014 | WO2014018774A1 Screening, diagnosis and prognosis of autism and other developmental disorders |
| 01/30/2014 | WO2014018757A1 Yeast cells having reductive tca pathway from pyruvate to succinate and overexpressing an exogenous nad(p)+ transhydrogenase enzyme |
| 01/30/2014 | WO2014018739A1 Methods and apparatuses using molecular fingerprints to provide targeted therapeutic strategies |
| 01/30/2014 | WO2014018679A2 Nme variant species expression and suppression |
| 01/30/2014 | WO2014018660A1 Functional genomics screening platform for head and neck cancer |
| 01/30/2014 | WO2014018602A1 Strains and methods for plasmid maintenance |
| 01/30/2014 | WO2014018596A2 Alpha (1,2) fucosyltransferases suitable for use in the production of fucosylated oligosaccharides |
| 01/30/2014 | WO2014018552A1 Xylose isomerases and their uses |
| 01/30/2014 | WO2014018549A2 Systems and methods for treatment of androgenetic skin conditions by microbial organisms |
| 01/30/2014 | WO2014018512A1 High-throughput dna fragment assembly |
| 01/30/2014 | WO2014018423A2 Inducible dna binding proteins and genome perturbation tools and applications thereof |
| 01/30/2014 | WO2014018117A1 An mva vaccine for delivery of a ul128 complex and preventing cmv infection |
| 01/30/2014 | WO2014018113A1 Oncolytic virus therapy for resistant tumors |
| 01/30/2014 | WO2014017941A1 Comprehensive promoter and use thereof in cancer gene therapy |
| 01/30/2014 | WO2014017851A2 Novel mars and method for producing target protein using the same |
| 01/30/2014 | WO2014017533A1 Method for cloning t cell receptor |
| 01/30/2014 | WO2014017493A1 Vaccine |
| 01/30/2014 | WO2014017491A1 Fusion gene of cep55 gene and ret gene |
| 01/30/2014 | WO2014017471A1 Melamine analyzing nucleic acid sensor, analyzing device, and analysis method |
| 01/30/2014 | WO2014017462A1 Pharmaceutical composition for inhibiting abnormal spine formation |
| 01/30/2014 | WO2014017394A1 Novel iron-zinc binding control factor, and technique for improving iron deficiency tolerance of plant and enhancing iron and zinc accumulation in edible part thereof by controlling expression of novel iron-zinc binding control factor |
| 01/30/2014 | WO2014017390A1 Nad-dependent glucose dehydrogenase and production method thereof |
| 01/30/2014 | WO2014017342A1 Indole derivative or pharmacologically acceptable salt thereof |
| 01/30/2014 | WO2014017319A1 Filaggrin production promoter, therapeutic agent for diseases associated with reduction in production of filaggrin, and method for screening for said therapeutic agent |
| 01/30/2014 | WO2014017187A1 Preparation method and preparation device for sample for nucleic acid amplification reaction |
| 01/30/2014 | WO2014017106A1 Compositions Comprising RAC Mutants, and Methods of Use Thereof |
| 01/30/2014 | WO2014017093A1 Benzene ring-fused, nitrogen-containing 5-membered heterocyclic compound or pharmacologically acceptable salt thereof |
| 01/30/2014 | WO2014017087A1 Pyrazolopyridine derivative or pharmacologically acceptable salt thereof |
| 01/30/2014 | WO2014016817A2 Nucleic acids for down-regulation of gene expression |
| 01/30/2014 | WO2014016580A1 Transgene expression |
| 01/30/2014 | WO2014016248A1 Protein with recombinase activity for site-specific dna-recombination |
| 01/30/2014 | WO2014015824A1 Method for screening micrornas with gene silencing function at both levels of transcription and post-transcription |
| 01/30/2014 | WO2014015804A1 Method for preparing homodimer protein mixture by using charge repulsion effect |
| 01/30/2014 | WO2014015706A1 Method for nondestructive detection of mirna expression in cell and determination of cell type and state |
| 01/30/2014 | WO2013186788A3 An expression vector containing strong promoter useful for high level expression of heterologous genes in schizosaccharomyces pombe and method for production of desired proteins thereof |
| 01/30/2014 | WO2013182553A3 CELL ENGINEERING USING RNAs |
| 01/30/2014 | WO2013173129A3 Treatment of amd using aav sflt-1 |
| 01/30/2014 | WO2013163654A3 Nucleic acids, cells, and methods for producing secreted proteins |
| 01/30/2014 | WO2013163628A3 Genetic correction of mutated genes |
| 01/30/2014 | WO2013163430A3 Serpinc1 irna compositions and methods of use thereof |
| 01/30/2014 | WO2013158227A8 Transgenic plants with enhanced traits |
| 01/30/2014 | WO2013155526A3 Sortase- modified vhh domains and uses thereof |